117 related articles for article (PubMed ID: 10221351)
21. Antihypertensive activity of alacepril in spontaneously hypertensive rats and deoxycorticosterone acetate-salt hypertensive rats and dogs.
Takeyama K; Minato H; Fukuya F; Kawahara S; Hosoki K; Kadokawa T
Arzneimittelforschung; 1985; 35(10):1507-12. PubMed ID: 3000390
[TBL] [Abstract][Full Text] [Related]
22. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.
Sugano M; Makino N; Yanaga T
Atherosclerosis; 1996 Nov; 127(1):123-9. PubMed ID: 9006812
[TBL] [Abstract][Full Text] [Related]
23. The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits.
Wojakowski W; Gminski J; Siemianowicz K; Goss M; Machalski M
J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):37-42. PubMed ID: 11881065
[TBL] [Abstract][Full Text] [Related]
24. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
25. The effect of angiotensin-converting enzyme inhibition on inflammatory and angiogenic factors in hypercholesterolemia.
Mahmoudabady M; Kazemi N; Niazmand S; Rezaee SA; Soukhtanloo M; Hosseini M
Pharmacol Rep; 2015 Oct; 67(5):837-41. PubMed ID: 26398373
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors.
Geng L; Persson K; Nilsson SF
J Ocul Pharmacol Ther; 2003 Dec; 19(6):589-98. PubMed ID: 14733716
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
28. An angiotensin converting enzyme inhibitor, perindopril, prevents progression of preformed atherosclerotic lesions in the cholesterol-fed rabbit.
Fennessy PA; Campbell JH; Campbell GR
Clin Sci (Lond); 1994 Dec; 87(6):685-91. PubMed ID: 7874860
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
Takai S; Jin D; Sakaguchi M; Muramatsu M; Ishii K; Kirimura K; Sakonjo H; Miyazaki M
Hypertens Res; 2004 Jul; 27(7):517-22. PubMed ID: 15302989
[TBL] [Abstract][Full Text] [Related]
30. Phenolic compounds from sandpaper (ficus exasperata) leaf inhibits angiotensin 1 converting enzyme in high cholesterol diet fed rats.
Oboh G; Akinyemi AJ; Osanyinlusi FR; Ademiluyi AO; Boligon AA; Athayde ML
J Ethnopharmacol; 2014 Nov; 157():119-25. PubMed ID: 25267581
[TBL] [Abstract][Full Text] [Related]
31. Beneficial effect of alacepril, a new angiotensin-converting enzyme inhibitor on albuminuria and glycemic state: an open multicenter trial. Alacepril Study Group.
Utsunomiya K; Ikeda Y
J Diabet Complications; 1991; 5(2-3):165-6. PubMed ID: 1770032
[TBL] [Abstract][Full Text] [Related]
32. Effects of angiotensin-converting enzyme inhibitor alacepril in patients with stable effort angina during chronic isosorbide dinitrate treatment.
Murohara T; Tayama S; Tabuchi T; Sumida H; Honda T; Hayasaki K; Yasue H
Am J Cardiol; 1996 Jun; 77(14):1159-63. PubMed ID: 8651088
[TBL] [Abstract][Full Text] [Related]
33. Free radical scavenging properties of alacepril metabolites and lisinopril.
Noda Y; Mori A; Packer L
Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
[TBL] [Abstract][Full Text] [Related]
34. Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.
Takeyama K; Minato H; Nakatsuji K; Suzuki H; Nose I; Oka M; Hosoki K; Hatano N; Kadokawa T
Arzneimittelforschung; 1986; 36(1):69-73. PubMed ID: 3513779
[TBL] [Abstract][Full Text] [Related]
35. Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture.
Fennessy PA; Campbell JH; Campbell GR
Atherosclerosis; 1994 Mar; 106(1):29-41. PubMed ID: 8018105
[TBL] [Abstract][Full Text] [Related]
36. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
[TBL] [Abstract][Full Text] [Related]
37. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
38. Effects of an angiotensin-converting enzyme inhibitor, alacepril, on cardiovascular and sympathetic nervous responses to mental stress in patients with essential hypertension.
Saitoh M; Miyakoda H; Kitamura H; Kinugawa T; Kotake H; Mashiba H
Intern Med; 1993 Sep; 32(9):691-4. PubMed ID: 8142672
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids.
Kowala MC; Grove RI; Aberg G
Atherosclerosis; 1994 Jul; 108(1):61-72. PubMed ID: 7980708
[TBL] [Abstract][Full Text] [Related]
40. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
